Author:
Schottelius Margret,Wirtz Martina,Eiber Matthias,Maurer Tobias,Wester Hans-Jürgen
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging
Reference11 articles.
1. Kiess A, Banerjee S, Mease R, Rowe S, Rao A, Foss C, et al. Prostate-specific membrane antigen as a target for cancer imaging and therapy. Q J Nucl Med Mol Imaging. 2015;59:241–68.
2. Weineisen M, Schottelius M, Simecek J, Baum RP, Yildiz A, Beykan S, et al. Ga-68- and Lu-177-labeled PSMA I&T: optimization of a PSMA-targeted theranostic concept and first proof-of-concept human studies. J Nucl Med. 2015;56:1169–76.
3. Banerjee SR, Pullambhatla M, Byun Y, Nimmagadda S, Green G, Fox JJ, et al. Ga-68-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer. J Med Chem. 2010;53:5333–41.
4. Weineisen M, Simecek J, Schottelius M, Schwaiger M, Wester HJ. Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer. EJNMMI Res. 2014;4(1):63.
5. Kulkarni H, Baum R, Weineisen M, Wester H, Schuchardt C, Wiessalla S, et al. Therapy of metastasized castrate-resistant prostate cancer using Lu-177 labeled DOTAGA-PSMA small molecules: first clinical results in a larger patient cohort. J Nucl Med. 2015;56(supplement 3):10.
Cited by
92 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献